uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands; Erasmus Choice Modelling Centre, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands; Department of Public Health, Erasmus MC – University Medical Centre, Dr. Molewaterplein 40, 3000 CA Rotterdam.
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands; Erasmus Choice Modelling Centre, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands.
Janssen Research & Development, 1125 Trenton-Harbourton Road, PO Box 200, Titusville, NJ, 08560, USA.
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands; Erasmus Choice Modelling Centre, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR the Netherlands.
Show others and affiliations
2019 (English)In: Drug Discovery Today, ISSN 1359-6446, E-ISSN 1878-5832Article in journal (Refereed) In press
Abstract [en]

Highlights

  • Preference studies are becoming increasingly important within the medical product decision-making context.
  • Currently, there is limited understanding of the range of methods to gain insights into patient preferences.
  • We developed a compendium and taxonomy of preference exploration (qualitative) and elicitation (quantitative) methods.
  • We identified 32 unique preference methods.
  • Our results can serve as an important resource for determining which preference methods are most promising in the medical product lifecycle.
Place, publisher, year, edition, pages
2019.
National Category
Pharmaceutical Sciences
Research subject
Social Pharmacy
Identifiers
URN: urn:nbn:se:uu:diva-383798DOI: 10.1016/j.drudis.2019.05.001OAI: oai:DiVA.org:uu-383798DiVA, id: diva2:1317213
Projects
IMI-PREFER
Funder
EU, European Research CouncilAvailable from: 2019-05-22 Created: 2019-05-22 Last updated: 2019-05-22

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Search in DiVA

By author/editor
Veldwijk, Jorien
In the same journal
Drug Discovery Today
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 45 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf